The results of in vitro and in vivo studies showed that the prepared nanoplatform successfully delivered cytotoxic protein RNase A and DSP into tumor cells, and induced intracellular RNA degradation mediated and nuclear DNA targeted killing of tumor cells, showing a good therapeutic effect on the tumor (Teng et al., 2021). This evidence concerns the gene RNASE1 and neoplasm.